Biomerieux.ca

16273
B - en - 2012/07
ETEST APPLICATION GUIDE
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
OX ≥ 4 µg/mL
and
OX ≥ 4 µg/mL
and XL ≤ 4 µg/mL
VA ≥ 8µg/mL
and
VISA/hVISA
1)
(macromethod) agar (BHI)
1)
Teicoplanin (TP)
1)
TP ≥12 µg/mL
(alone) = VISA/hVISA
Etest GRD
2) (Vancomycin (VA) /
Teicoplanin (TP)
1))
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
Teicoplanin (TP)
1)
Quinupristin/dalfopristin (QDA)
Rifampicin (RI)
1)
Teicoplanin (TP)
1) Ciprofloxacin (CI)
Teicoplanin (TP)
1) Minocycline (MC)
Streptomycin (SM) high range
1)
GM > 128 µg/mL = positive HLAR (EUCAST)
Gentamicin (GM) Piperacillin/ tazobactam (PTc)
(PM/PML)
1)
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
MBL IP/IPI
1)
Imipenem/imipenem + EDTA (IP/IPI) 48h for slow Ambient air
Stenotrophomonas 13636TM
MBL IP/IPI
1)
Imipenem/imipenem + EDTA (IP/IPI) 48h for slow Ambient air
Stenotrophomonas 13636TM
FASTIDIOUS ORGANISMS
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
Clindamycin (CM)
1)
Vancomycin (VA) Trimethoprim/sulfamethoxazole (TS)
Linezolid (LZ)
1)
5)
Granulicatella spp.
1)
(or BHI broth) Trimethoprim/sulfamethoxazole (TS)
Moraxella catarrhalis 1)
5)
5)
Broth + vit K3) Piperacillin/tazobactam (PTc)
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
- 1 strip/90mm plate - Strip handle to be
Helicobacter pylori 1)
Spectinomycin (SC)
1)
Meningococci
1)
Campylobacter spp.
1)
Tilt plate and use oblique light to read endpoint.
FASTIDIOUS GRAM-POSITIVE ORGANISMS 1)
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
Arcanobacterium spp.,
Listeria monocytogenes*,
Erysipelothrix,
Lactobacillus,
5)
Rothia,
Pediococcus*,
Leuconostoc*, and
Gemella spp.*
FASTIDIOUS GRAM-NEGATIVE ORGANISMS 1)
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
10% blood
1) (or +
2% haemoglobin
3))
MYCOBACTERIA AND AEROBIC ACTINOMYCETES 1)
RECOMMENED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
M7H9 broth + 0.5% tween + 2% glycerol Vortex with
& adjust supernatant to correct turbidity.
(
M. marinum M. avium spp.
avium 35713TM
Amikacin (AK) Trimethoprim/sulfamethoxazole (TS)
RECOMMENDED
INOCULUM INCUBATION
SPECIFIC
QUALITY CONTROL
ORGANISM
SUGGESTED MIC PANEL 3)
COMMENTS 4)
PHENOTYPE
Amphotericin B (AP)
1)
Caspofungin (CS)
1)
Amphotericin B (AP)
1)
Voriconazole (VO)
1)
Posaconazole (POS)
1)
Caspofungin (CS)
1)
1)
In the USA, For Research Use Only (RUO). The contents of this document do not in any way indicate or imply new in vitro diagnostic uses of Etest, outside those which are FDA-cleared for certain
antibiotics and organism groups.
2) Worldwide, For Research Use Only (RUO). 3) Example based on CLSI®, Performance Standards for Antimicrobial Susceptibility Testing supplement M100-S. Please use your own selection of MIC panels. 4) Additional Etest information is available at www.biomerieux.com/techlib. 5) For QC of fastidious organisms, please refer to local recommendations and/or CLSI M45-A Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. 6) For media available in the bioMérieux range, see page 10 (consult www.biomerieux.com/techlib for availability of certificates of compatibility).
KEY:
BORSA
Borderline ORSA (non-mec A resistance) due to type A macro-inducible ß-lactamase inhibited by clavulanic acid
BSC Biological
HLAR High-Level
MBL Metallo
MRCNS Methicillin-Resistant
Coagulase-Negative Staphylococci (mec A+)
MRSA Methicillin-Resistant
ND Non-Determinable
OADC
VISA/hVISA
Vancomycin Intermediate/ hetero-Intermediate
Staphylococcus aureus
MEDIA AVAILABLE IN THE BIOMERIEUX RANGE
Consult the bioMerieux Technical Library (www.biomerieux.com\techlib) for availability of certificates of compatibility
For non-fastidious bacteria:
For fastidious bacteria:
bioMérieux Ref. 43301/43309 - 20 / 100 plates 90 mm
• Mueller Hinton 2 horse blood NAD agar
bioMérieux Ref. 43302 - 20 plates 145 mm
bioMérieux Ref. 43901/43919 - 20 / 100 plates 90 mm
bioMérieux Ref. 43511 - 20 plates 120 x 120 mm
bioMérieux Ref. 43904 - 20 plates 120 x 120 mm
bioMérieux Ref. 43321/43329 - 20 / 100 plates 90 mm bioMérieux Ref. 43324 - 20 plates 120 x 120 mm
For anaerobes:
For fungi and yeasts:
• Brucella blood agar (with Vitamin K1 + Hemin)
bioMérieux Ref. 411 968 - 20 plates 90 mm
bioMérieux Ref. AEB 122 180 - 10 plates 90 mm
bioMérieux Ref. AEB 122 182 - 10 plates 140 mm
SUSPENSION MEDIA AVAILABLE IN THE BIOMERIEUX RANGE
bioMérieux Ref. 20040 – 100 x 3ml bioMérieux Ref. 20230 – 100 x 5ml
BIOMERIEUX, the blue logo, API and Etest are used pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies. CLSI is a registered trademark belonging to Clinical and Laboratory Standards Institute, Inc. The ATCC trademark and trade name and any and all ATCC catalog numbers are trademarks of the American Type Culture Collection. Any other name or trademark is the property of its respective owner.
bioMérieux SA
www.biomerieux.com
Source: http://www.biomerieux.ca/upload/Supplementary_Inserts_-_16273_-_B_-_en_-_EAG_-_Etest_Application_Guide-4.pdf
LEPTIN LEVELS IN TREATING PREMATURE EJACULATIONM. ATMACA Serum leptin levels in patients with premature ejaculation before and after citalopram treatment M. ATMACA, M. KULOGLU, E. TEZCAN, B. USTUNDAG* and A. SEMERCIOZ† Departments of Psychiatry, *Clinical Biochemistry and †Urology, Firat University, School of Medicine, Elazig, Turkey OBJECTIVE serotonergic systems. In a previous stud
ADENOSINE (Adenocard) ADULT - 1ST dose 6 mg IVP, 2ND dose 12 mg IVP PED- 1ST DOSE 0.1 mg/kg up to 6 mg 2ND DOSE 0.2 mg/kg up to 6 mg **Contact base after 2nd dose if no improvement ALBUTEROL SULFATE ADULT - 2.5 mg/3ml PED- 0.15 mg/kg up to 10 mg in NS Continuous nebulizer 0.5 mg/kg/hr max 15 mg/hr AMIODARONE (Cordarone) A. Cardiac Arrest, VF/Pulseless VT: 1st dos